Abstract:The use of multi-epitopes has been considered as a promising strategy to overcome the obstacle of antigenic variation in malarial vaccine development. Previously, we constructed a multi-epitope artificial antigen, Malaria Random Constructed Antigen-1(M.RCAg-1), to optimize expression of the antigen, and we subcloned the gene into three prokaryotic expression vectors that contain different fusion tags at the N-terminus. Three recombinant proteins expressed by these vectors, named M.RCAg-1/Exp.V-1, V-2, and V-3, were purified after the cleavage of the fusion tag. All three recombinant proteins were able to induce similar levels of antigenicity in BALB/c murine models. However, the antibody responses against the individual epitope peptides of the recombinant products were dramatically different. Additionally, the different epitopes elicited various CD4(+) T-cell responses, as shown by the resulting lymphocyte proliferation and varied IFN-gamma and IL-4 levels determined by EILSPOT; however, each could be distinctly recognized by sera derived from malaria patients. Additionally, the rabbit antibody induced by these proteins showed diverse efficacy in malaria parasite growth inhibition assays in vitro. Furthermore, analysis via circular dichroism spectroscopy confirmed that the secondary structure was different among these recombinant proteins. These results suggest that the expressed multi-epitope artificial antigens originating from the different vector fusion peptides indeed affect the protein folding and, subsequently, the epitope exposure. Thus, these proteins are able to induce both distinct humoral and cellular immune responses in animal models, and they affect the efficacy of immune inhibition against the parasite. This work should lead to a further understanding of the impact of vector fusion peptides on the conformation and immune reactivity of recombinant proteins and could provide a useful reference for the development of artificial multi-epitope vaccines.

Comparison of Immune Responses Elicited by Recombinant Fusion Hapten and Coupled Hapten

Hapten Design and Antibody Preparation of Fipronil

Immunoprotection of Recombinant Antigen LTB-UreB-HpaA in Helicobacter Pylori Infected Mice and Immunoenhancement of the Inner Adjuvant LTB

Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome.

DIFFERENT FACTORS AFFECTING ANTIBODY RESPONSES IN MICE IMMUNIZED BY GENE RECOMBINANT OF HCV STRUCTURE REGION

Hapten Design,Modification and Preparation of Artificial Antigens

Comparison on the Immune Responses Induced by the EG95 Hydatid Vaccine and the Recombinant EG95 Antigen in Mice

Effects of vector fusion peptides on the conformation and immune reactivity of epitope-shuffled, recombinant multi-epitope antigens.

Comparison of polyclonal anti-sera against extracellular domain of hepatoma associated antigen HAb18G/CD147 prepared by different immunization schemes]

Comparison of Antibody Immune responses to different HIV-1 Envelope Glycoprotein Mutants.

[The Immunization Effects of HBV Core Antigen and Surface Antigen Fusion Protein in Mice].

Preparation of a Fusion Protein with Pneumococcal Surface Protein A of Two Different Clades of Familyⅰand Analysis of Immunogenicity of the Recombinant Protein

Characteristics of Rabbit Hapten-Specific and Germline-Based BCR Repertoires Following Repeated Immunization

Evaluation of the Immunity Effectiveness on the Engineered Subunit Vaccine of Staphylococcus Aureus Α-Hemolysin

The effect of immunogenicity of antigenic preparations from enterotoxigenic Escherichia coli on laying hens

IMMUNOASSAY OF RECOMBINANT HYPODERMIN A

Preliminary Immune Effect Evaluation of Two ADV Recombinant DNA Vaccines

Fusion of hC3d3 to hCGβ enhances responsiveness in vitro of human peripheral immunocompetent cells upon the antigen primary challenge

Immunogenic Comparison for Two Different Recombinant Chimeric Peptides (CP12 and CP22) Containing One or Two Copies of Three Linear B Cell Epitopes from Β-Hcg Subunit

Immune Response Induced by a Different Combined Immunization of HBsAg Vaccine

Combined Immunization of HIV-2 Group Antigen Gene Recombinant Vaccines Inflict Higher Immune Response